160 related articles for article (PubMed ID: 9260875)
1. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2.
Condie R; Herring A; Koh WS; Lee M; Kaminski NE
J Biol Chem; 1996 May; 271(22):13175-83. PubMed ID: 8662742
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
Herring AC; Koh WS; Kaminski NE
Biochem Pharmacol; 1998 Apr; 55(7):1013-23. PubMed ID: 9605425
[TBL] [Abstract][Full Text] [Related]
5. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase.
Bayewitch M; Rhee MH; Avidor-Reiss T; Breuer A; Mechoulam R; Vogel Z
J Biol Chem; 1996 Apr; 271(17):9902-5. PubMed ID: 8626625
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
[TBL] [Abstract][Full Text] [Related]
7. Transient CRE- and kappa B site-binding is cross-regulated by cAMP-dependent protein kinase and a protein phosphatase in mouse splenocytes.
Koh WS; Jeon YJ; Herring AC; Kaminski NE
Life Sci; 1997; 60(6):425-32. PubMed ID: 9031689
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
9. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria BC; Das SK; Dey SK
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
[TBL] [Abstract][Full Text] [Related]
10. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
11. Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
Sánchez C; Velasco G; Guzmán M
Life Sci; 1997; 60(19):1709-17. PubMed ID: 9129126
[TBL] [Abstract][Full Text] [Related]
12. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
13. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
14. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
[TBL] [Abstract][Full Text] [Related]
15. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
16. Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.
Herring AC; Kaminski NE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1156-63. PubMed ID: 10565837
[TBL] [Abstract][Full Text] [Related]
17. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.
Sánchez C; Galve-Roperh I; Rueda D; Guzmán M
Mol Pharmacol; 1998 Nov; 54(5):834-43. PubMed ID: 9804618
[TBL] [Abstract][Full Text] [Related]
18. Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation. Association with protein kinase A-mediated phosphorylation of phospholipase C-gamma 1.
Alava MA; DeBell KE; Conti A; Hoffman T; Bonvini E
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):189-99. PubMed ID: 1318020
[TBL] [Abstract][Full Text] [Related]
19. The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol.
Lee MC; Smith FL; Stevens DL; Welch SP
J Pharmacol Exp Ther; 2003 May; 305(2):593-9. PubMed ID: 12606657
[TBL] [Abstract][Full Text] [Related]
20. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
Dhawan K; Kumar S; Sharma A
J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]